In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Félix Javier Jiménez-JiménezSection of Neurology, Hospital Universitario del Sureste, 28500 Arganda del Rey, Madrid, Spain.ORCID 0000-0002-7558-7323 Sofía Ladera-NavarroUniversity Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, 10003 Cáceres, Spain.ORCID 0009-0007-0706-0179 Hortensia Alonso-NavarroSection of Neurology, Hospital Universitario del Sureste, 28500 Arganda del Rey, Madrid, Spain.ORCID 0000-0001-8644-2210 Pedro AyusoUniversity Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, 10003 Cáceres, Spain.ORCID 0000-0002-9441-4022 Laura Turpín-FenollSection of Neurology, Hospital La Mancha-Centro, 13600 Alcázar de San Juan, Ciudad Real, Spain.
Jorge Millán-PascualSection of Neurology, Hospital La Mancha-Centro, 13600 Alcázar de San Juan, Ciudad Real, Spain.ORCID 0000-0003-2112-5964 Ignacio ÁlvarezMovement Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, 08221 Terrassa, Barcelona, Spain.ORCID 0000-0002-8537-3935 Pau PastorUnit of Neurodegenerative Diseases, Department of Neurology, University Hospital Germans Trias i Pujol, The Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Barcelona, Spain.ORCID 0000-0002-7493-8777 Alba Cárcamo-FonfríaSection of Neurology, Hospital Universitario del Sureste, 28500 Arganda del Rey, Madrid, Spain.ORCID 0000-0002-9928-6293 Marisol CallejaSection of Neurology, Hospital Universitario del Sureste, 28500 Arganda del Rey, Madrid, Spain.
Santiago Navarro-MuñozSection of Neurology, Hospital La Mancha-Centro, 13600 Alcázar de San Juan, Ciudad Real, Spain.
Esteban García-AlbeaDepartment of Medicine-Neurology, Universidad de Alcalá, 28801 Alcalá de Henares, Madrid, Spain.
Elena García-MartínUniversity Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, 10003 Cáceres, Spain.ORCID 0000-0002-8094-046X José A G AgúndezUniversity Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, 10003 Cáceres, Spain.ORCID 0000-0001-6895-9160 Funding
Instituto de Salud Carlos III PI21/01683Instituto de Salud Carlos III PI24/01358
6 · The paper itselfAbstract
The MAM domain-containing glycosylphosphatidylinositol anchor 1 (
Indexed as
Genetic Predisposition to DiseasePolymorphism, Single NucleotideRestless Legs SyndromeAdultAgedAllelesCase-Control StudiesFemaleGene FrequencyGenotypeHumansMaleMiddle Agedgenetic polymorphismsgeneticsMDGA1 generestless legs syndromerisk factors
Identifiers
PMID40724952
PMCPMC12295006
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390